SeraCare Life Sciences SeraSure FBS is a cell culture Fetal Bovine Serum PCR-tested negative for BVD. While FBS providers have historically assured customers that their serum is tested for bovine diarrhea virus (BVD), those results are not always conclusive.
As a result, many customers opt to use chemical or irradiation processes to
inactivate the virus, adding time and expense to their projects and
potentially affecting downstream applications. SeraCare employs PCR testing
at both the collection pool stage and the finished goods stage, with serum
collected from dedicated harvest facilities to ensure high quality and
consistency across lots. Customers can test and sample multiple lots prior
to purchase to ensure the right fit for their particular assay, and can
obtain SeraSure FBS in large lots to meet high-volume research needs. Upon
request, SeraCare will reserve SeraSure FBS in customer-specified quantities
while lots are being sampled, to ensure a readily available supply when
needed.
SeraCare serves the global life sciences industry by providing vital products
and services to facilitate the discovery, development and production of
human diagnostics and therapeutics. The Company's innovative portfolio
includes diagnostic controls, plasma-derived reagents and molecular
biomarkers, biobanking and contract research services. SeraCare's quality
systems, scientific expertise and state-of-the-art facilities support its
customers in meeting the stringent requirements of the highly regulated life
sciences industry.